Psilocybin Access Rights
Seeking the rescheduling of psilocybin on scientific merits.
10/03/2026
Matthew W. Johnson
Just published: our RCT shows psilocybin (magic mushrooms) dramatically beats ni****ne patch for quitting smoking using the same psychotherapy! A single psilocybin session showed 6x greater odds of staying quit. Biologically verified. In
06/03/2026
Here are 5 studies showing that Psilocybin can save lives, copy the link into your browser to read the full articles:
1) Psilocybin assisted therapy provides a breakthrough in the treatment of addiction. 80% of patients with chronic to***co addiction.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5641975/
2)In one study, over half of study participants were in remission from their depression symptoms 12 months after only two doses.
https://pubmed.ncbi.nlm.nih.gov/35166158/
3) A recent study found that psilocybin had a significantly greater impact on both thought suppression and rumination, in comparison to escitalopram.
https://pubmed.ncbi.nlm.nih.gov/36065128/
4) Psilocybin has proven effective in treating treatment-resistant depression, with 100% of study participants’ symptoms reduced one week after a single treatment, and 47% five weeks after.
https://pubmed.ncbi.nlm.nih.gov/29030624/
5) Psilocybin assisted therapy was shown to be effective in the treatment of alcoholism, with the percentage of heavy drinking days post-treatment decreasing by over double the amount of an active placebo group.
https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2795625
03/03/2026
Here are 5 studies showing that Psilocybin can save lives, click on the link to read the full articles:
1) Psilocybin assisted therapy provides a breakthrough in the treatment of addiction. 80% of patients with chronic to***co addiction https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641975/
2)In one study, over half of study participants were in remission from their depression symptoms 12 months after only two doses.
https://pubmed.ncbi.nlm.nih.gov/35166158/
3) A recent study found that psilocybin had a significantly greater impact on both thought suppression and rumination, in comparison to escitalopram.
https://pubmed.ncbi.nlm.nih.gov/36065128/
4) Psilocybin has proven effective in treating treatment-resistant depression, with 100% of study participants’ symptoms reduced one week after a single treatment, and 47% five weeks after.
https://pubmed.ncbi.nlm.nih.gov/29030624/
5) Psilocybin assisted therapy was shown to be effective in the treatment of alcoholism, with the percentage of heavy drinking days post-treatment decreasing by over double the amount of an active placebo group.
https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2795625
09/02/2026
Swipe to understand the difference between Drug Scheduling and Drug Classification in the UK>
08/02/2026
Swipe to read 5 Fantastic Fungi Facts>>
07/02/2026
Meet Sarah PAR’s Festival and Merchandise Coordinator!
🍄Swipe to learn more about her!
14/01/2026
In the new program How to Keep Your Brain Young, Dr. Amir Khan dives into the cutting-edge science of cognitive health. While we know diet and exercise matter, the show explores the “frontier” of brain care—including how psilocybin is being researched by experts like to revolutionize how we treat depression and addiction.
The science is clear: our brains are more adaptable than we think. From lifestyle shifts to the potential of psychedelic therapies, it’s never too late to sharpen your mind.
Check out How to Keep Your Brain Young to see the future of mental health care in action. 📺
Tonight Jan 14th on at 19:00 (7pm)
For more info on the PAR (Psilocybin Access Rights) campaign, visit links in bio.
17/12/2025
🌟CHRISTMAS GIVEAWAY COMPETITION🌟 Enter our competition for the chance to win one of our Christmas Jumpers (size large).
Enter by… 🎄Liking this post 🎄Tagging 5 friends in the comments 🎄Making sure that you follow our account .global
28/11/2025
Our amazing Christmas jumper is available online! Link in our bio!!!!
19/11/2025
Our boy Timmy Davis is on the panel|!!!😁
People before profits, patients before patents, equity of safe access to treatment - we can all agree on this, but is it the reality of how the future of psychedelic-assisted therapy is forming? How do we build a psychedelic ecosystem rooted in inclusivity, community care, safety, equity and accessibility in the face of increasing corporatisation and the profit motives and corner-cutting that can often come with it?
We're very happy to be exploring these vital questions and many more with a fantastic collection of speakers on Saturday 22 November, when PsyAware and The Maudsley Psychedelic Society are hosting the event in London and online: 'The Future Is Psychedelic(?): Community, Care, Access, and Resistance'. The event runs from 13:00 to 20:30 (GMT UK). Sign up for your in-person or online ticket here thefutureispsychedelic.eventbrite.co.uk - PsyPAN community members can use the code PSYPAN20 for a 20% discount.
episode of “What’s Up Docs?” delivers a fascinating episode with identical twin doctors Chris and Xand van Tulleken. This week, they speak to Dr James Rucker, a consultant psychiatrist at King’s College London, about groundbreaking research into psilocybin as a potential treatment for severe depression where other medications have failed. The hosts explore the long history of psychedelic use in medicine and spirituality, from pe**te and ayahuasca to L*D, and discuss the growing scientific optimism for using these substances in treating conditions like anxiety, eating disorders, and addiction. It’s a thought‑provoking listen that blends history, science, and hope for future therapies.
For more info on the PAR (Psilocybin Access Rights) campaign, visit links in bio. #
Click here to claim your Sponsored Listing.